<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the epidemiology, clinical characteristics and prognosis of children with pulmonary arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (<z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi>) secondary to <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> (CTD) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The clinical record files of the pediatric inpatient with <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> in the population of CTD in the hospital treated between January 2000 and January 2007 were analyzed retrospectively </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: (1) In 299 patients with CTD and complete Doppler echocardiography files, 31 (31/299, 10.4%) patients (28 females and 3 males), aged from 7 to 18 years (average: 12.5 years), were found to have <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi>, in whom, 5(62.5%)in 8 patients with overlapped CTD (OCTD), 2 (50.0%) in 4 patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), 4(28.6%) in 14 patients with systematic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (SV), 3 (10.7%) in 28 patients with <z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">dermatomyositis</z:e> (DM), 17(7.6%) in 223 <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) had <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The CTD-associated <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> occurred in the 3rd week to 5th year after initial CTD manifestations (median <z:hpo ids='HP_0003674'>onset</z:hpo>: 1.5 years) </plain></SENT>
<SENT sid="4" pm="."><plain>(2) The <z:hpo ids='HP_0003674'>onset</z:hpo> of CTD-associated <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> was obscure and children with severe CTD-associated <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> presented with <z:hpo ids='HP_0002094'>dyspnea</z:hpo> (18/31, 58.1%) and <z:hpo ids='HP_0001635'>heart failure</z:hpo> (9/31, 29.0%) </plain></SENT>
<SENT sid="5" pm="."><plain>The children with <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud's phenomenon</z:e> or positive anticardiophospholipid antibody (ACL) or positive <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) were prone to have more severe <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>(3) Doppler echocardiography and pulmonary function test, especially the test of pulmonary diffusion function of CO (D(LCO)) were necessary to detect <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> early </plain></SENT>
<SENT sid="7" pm="."><plain>(4) After treatment, the pulmonary arterial pressure in mild and moderate <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> cases could be normalized and in severe <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> cases could be decreased to mild or moderate levels </plain></SENT>
<SENT sid="8" pm="."><plain>There was a lower PaO(2) level (P &lt; 0.01), a higher pulmonary arterial systolic pressure (PASP) level (P &lt; 0.05) in the cases of CTD-<z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> who died as compared with the live patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> is a common complication of CTDs, which occurs often 1.5 years after initial CTD manifestations </plain></SENT>
<SENT sid="10" pm="."><plain>The early associated symptom is obscure and the severe cases manifest with <z:hpo ids='HP_0002094'>dyspnea</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Those with <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud's phenomenon</z:e> and positive ACL and LA are prone to develop more severe <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> </plain></SENT>
<SENT sid="12" pm="."><plain>Early and regular Doppler echocardiography and pulmonary function test are necessary to detect <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> early </plain></SENT>
<SENT sid="13" pm="."><plain>Severe CTD associated <z:chebi fb="11" ids="104011,31204,33848,53305">PAH</z:chebi> in children could lead to poor outcome </plain></SENT>
<SENT sid="14" pm="."><plain>PASP classification and PaO(2) level are important factors affecting prognosis </plain></SENT>
</text></document>